Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Pulmonary infection is a common complication in pediatric living donor liver transplantation (LDLT) recipients. It has been suggested that vitamin D has a role in immune defense against infection. Therefore, we investigated the effect of preoperative serum 25‐hydroxyvitamin D<sub>3</sub> (25(OH)D<sub>3</sub>) on the risk of pneumonia in hospitalized patients undergoing LDLT. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Materials and Methods</h3><p>This study was a retrospective review of patient records. Fifty consecutive pediatric patients (aged <14 years) who underwent LDLT from January 2017 to December 2017 were included. Pulmonary infection in the early postoperative period was diagnosed using clinical, radiological, or laboratory criteria. Preoperative serum 25(OH)D<sub>3</sub> level, demographic characteristics, primary diagnosis, ascites, time to extubation, length of intensive care unit stay and perioperative laboratory values were recorded. Vitamin D deficiency, insufficiency, and sufficiency were defined as a serum 25(OH)D<sub>3</sub> concentration of <10, 10‐20, and >20 ng/mL, respectively. Associations between serum 25(OH)D<sub>3</sub> levels and pulmonary infection were analyzed. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Of 50 pediatric patients who underwent LDLT, 19 (38%) developed pulmonary infections in the early postoperative period. The mean serum 25(OH)D<sub>3</sub> level in these subjects was 18.7±17.2 ng/mL (range 3.0–70.0 ng/mL). Twenty patients (40%) had severe vitamin D deficiency (<10 ng/mL). The mean serum 25(OH) D<sub>3</sub> level was significantly decreased (9.3±7.4 <i>vs </i> 24.5 ± 19.1 ng/mL, <i>p </i> = 0.002) in patients with pulmonary infection compared to those without pulmonary infection. Serum 25(OH)D<sub>3</sub> level as a continuous variable (odds ratio (OR) 0.90, 95% confidence interval (CI) 0.84‐0.97, <i>P </i> = 0.008) and a classification variable (≤10 ng/mL) (OR 7.42, 95% CI, 2.06‐26.79, <i>P </i> = 0.002) were significantly associated with pulmonary infection in univariate analysis. After adjusting for other significant predictors (age, weight and pediatric end‐stage liver disease (PELD) score), severe 25(OH)D<sub>3</sub> deficiency at presentation was independently associated with a higher risk of developing pulmonary infection in the early postoperative period (OR 5.11, 95% CI, 1.30‐20.16, <i>p </i> = 0.02). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>25(OH)D<sub>3</sub> deficiency is common and inversely correlated with pulmonary infection within the first month after pediatric LDLT. Our results indicate that pre‐operative serum 25(OH)D<sub>3</sub> deficiency is a potential biomarker for early pulmonary infection after pediatric LDLT. </p><p>This article is protected by copyright. All rights reserved.</p></section>

Associations Between Vitamin D and Liver Function and Liver Fibrosis in Patients with Biliary Atresia

Effect and Mechanism of Vitamin D Activation Disorder on Liver Fibrosis in Biliary Atresia

Fat-Soluble Vitamin Deficiency in Pediatric Patients with Biliary Atresia

Expression level of vitamin D receptor in intrahepatic bile duct epithelial cells and its clinical significance in children with biliary atresia

Serum TGF-β1 and VEGF Levels Reflect the Liver Hardness and Function in Children with Biliary Atresia

Association of 25-Hydroxyvitamin D with Liver Cancer Incidence and Chronic Liver Disease Mortality in Finnish Male Smokers of the ATBC Study.

The Aberrant Expression of HLA-DR in Intrahepatic Bile Ducts in Patients with Biliary Atresia: an Immunohistochemistry and Immune Electron Microscopy Study.

Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women.

Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis.

Decreased Vitamin D-binding Protein Level Portends Poor Outcome in Acute-on-chronic Liver Failure Caused by Hepatitis B Virus.

Vitamin D Serum Level is Associated with Child–Pugh Score and Metabolic Enzyme Imbalances, but Not Viral Load in Chronic Hepatitis B Patients

Serum vitamin D is associated with ultrasound-defined hepatic fibrosis

[Prospective Study on the Relation Between Serum Vitamin D Levels and Liver Cirrhosis Risk].

Correlation of Interleukin-33/ST2 Receptor and Liver Fibrosis Progression in Biliary Atresia Patients.

Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease

Severe Vitamin D Deficiency is Strongly Associated with Liver Dysfunction and Disease Severity in Hepatitis B Virus Related Cirrhosis and Liver Failure Patients

Preoperative serum 25‐hydroxyvitamin D 3 and the incidence of early pulmonary infection after pediatric living donor liver transplantation

Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data

Evaluation of hepatic fibrosis using Aspartate aminotransferase-to-Platelet Ratio Index in children with biliary atresia

Association between serum vitamin D concentration and liver fibrosis in diabetes mellitus patients: a cross-sectional study from the NHANES database

Progress in Biomarkers Related to Biliary Atresia